September 20, 2012 - Northern Trust First in Northern Ireland to Deploy AutoPulse for Improved Cardiac Arrest Treatment
MEDIA CONTACT: |
Diane Egan |
NORTHERN TRUST FIRST IN NORTHERN IRELAND TO DEPLOY AUTOPULSE FOR IMPROVED CARDIAC ARREST TREATMENT
September 20, 2012—Coleraine—The Northern Trust’s Causeway Hospital is the first in Northern Ireland to deploy the ZOLL AutoPulse® Non-Invasive Cardiac Support Pump, an automated, portable chest compression device to assist in resuscitation of cardiac arrest patients.
Last year approximately 70 patients in Causeway Hospital suffered a cardiac arrest requiring resuscitation. Although traditionally CPR compressions are performed manually and are invaluable in saving lives, there can be a downside. In complicated cases staff may have to give compressions for a number of hours, which is extremely tiring and may result in gaps in treatment during which blood does not circulate to the heart and brain.
The AutoPulse’s easy-to-use, load-distributing LifeBand® squeezes the entire chest, tirelessly delivering consistent, high-quality compressions.
 |
Donna Hanna, Lead Nurse for Specialist Medicine; Dr Charles Jack, Consultant Physician; Elaine Herald, Sister in Coronary Care Ward and Adam Hanna, Resuscitation Officer at Causeway Hospital, carry out training using the AutoPulse. |
“During a cardiac arrest every second counts. Using the AutoPulse is like having another member of staff on the team who never gets tired and always gives high-quality compressions while other staff members are free to provide further lifesaving care,” Adam Hanna, Resuscitation Officer at Causeway Hospital said. “The AutoPulse compresses the whole chest and as a result the force is spread across the chest, improving blood flow to the heart and brain and helping avoid complications, potentially giving the patient a better chance of surviving.”
The device is based in the Coronary Care Unit at Causeway Hospital and can reach any part of the hospital within two minutes.
“Causeway Hospital’s staff is to be commended for efforts to improve care and optimize chances of survival from sudden cardiac arrest,” said Jonathan A. Rennert, President of ZOLL. “The ability to provide consistent, uninterrupted chest compressions is a critical aspect of quality CPR.”
About the AutoPulse
The AutoPulse is an automated, portable chest compression device with an easy-to-use, load-distributing LifeBand that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest. The AutoPulse delivers high-quality, uninterrupted CPR chest compressions to maintain myocardial and cerebral perfusion even when moving patients, traveling in an ambulance or while a patient is undergoing emergent cathertization for PCI. Additionally, it offers the benefit of freeing up clinicians to focus on other life-saving interventions.
About Sudden Cardiac Arrest
SCA, an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs, claims more than one million lives globally each year. It is the leading cause of unexpected death in the world and strikes without warning. Survival is poor at less than eight percent, but improvements in resuscitation practices could save as many as half of these victims.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2012 ZOLL Medical Corporation. All rights reserved. AutoPulse, LifeBand, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All product names are the property of their respective owners.